Issue
Alert me when new journal issues are available via or via
Update on the mechanism of action of bimatoprost: a review and discussion of new evidence Achim H.-P. Krauss, David F. Woodward pages S5-S11 Abstract | Full Text | Full-Text PDF (198 KB)
A randomized, investigator-masked comparison of diurnal responder rates with bimatoprost and latanoprost in the lowering of intraocular pressure Neil Choplin, Paula Bernstein, Amy L. Batoosingh, Scott M. Whitcup, for the Bimatoprost/Latanoprost Study Group pages S19-S25 Abstract | Full Text | Full-Text PDF (168 KB)
Two-year double-masked comparison of bimatoprost with timolol in patients with glaucoma or ocular hypertension John S Cohen, Ronald L Gross, Janet K Cheetham, Amanda M VanDenburgh, Paula Bernstein, Scott M Whitcup pages S45-S52 Abstract | Full Text | Full-Text PDF (203 KB)
24-Hour IOP control with once-daily bimatoprost, timolol gel-forming solution, or latanoprost: a 1-month, randomized, comparative clinical trial Thomas R Walters, Harvey B DuBiner, Susan P Carpenter, Bashir Khan, Amanda M VanDenburgh, for the Bimatoprost Circadian IOP Study Group pages S26-S35 Abstract | Full Text | Full-Text PDF (287 KB)
A Cost-effectiveness comparison of bimatoprost versus latanoprost in patients with glaucoma or ocular hypertension John G. Walt, Jeffrey T. Lee pages S36-S44 Abstract | Full Text | Full-Text PDF (235 KB)
Introductory comments
Bimatoprost: Establishing its role in glaucoma management L.Jay Katz pages S1-S4 Full Text | Full-Text PDF (76 KB)
Ocular hypotensive efficacy of bimatoprost 0.03% and travoprost 0.004% in patients with glaucoma or ocular hypertension Louis B. Cantor, Darrell WuDunn, Arnold Cortes, Joni Hoop, Stephenie Knotts pages S12-S18 Abstract | Full Text | Full-Text PDF (316 KB)
Copyright © 2010 Elsevier, Inc. All rights reserved | Privacy Policy | Terms & Conditions | Feedback | About Us | Help | Contact Us | The content on this site is intended for health professionals.
